| 标题 |
Efficacy and safety of sulbactam-durlobactam versus colistin for the treatment of patients with serious infections caused by Acinetobacter baumannii-calcoaceticus complex: a multicentre, randomised, active-controlled, phase 3, non-inferiority clinical trial (ATTACK) 舒巴坦杜罗巴坦(SUL-DUR)与粘菌素治疗鲍曼不动杆菌-醋酸钙复合物(ABC)感染患者的疗效和安全性:一项全球性、随机、活性对照3期试验(ATTACK)
|
| 网址 | |
| DOI |
10.1016/S1473-3099(23)00184-6
doi
|
| 其它 | Kaye KS, Shorr AF, Wunderink RG, et al. Efficacy and safety of sulbactam-durlobactam versus colistin for the treatment of patients with serious infections caused by Acinetobacter baumannii-calcoaceticus complex: a multicentre, randomised, active-controlled, phase 3, non-inferiority clinical trial (ATTACK). Lancet Infect Dis. 2023;23(9):1072-1084. doi:10.1016/S1473-3099(23)00184-6 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)